Search Results

There are 282470 results for: content related to: Efficacy and safety of neoadjuvant trastuzumab combined with paclitaxel and epirubicin

  1. Trastuzumab containing regimens for early breast cancer

    Intervention Review

    The Cochrane Library

    Lorenzo Moja, Ludovica Tagliabue, Sara Balduzzi, Elena Parmelli, Vanna Pistotti, Valentina Guarneri and Roberto D'Amico

    Published Online : 18 APR 2012, DOI: 10.1002/14651858.CD006243.pub2

  2. You have full text access to this OnlineOpen article
    Calpain4 is required for activation of HER2 in breast cancer cells exposed to trastuzumab and its suppression decreases survival and enhances response

    International Journal of Cancer

    Volume 131, Issue 10, 15 November 2012, Pages: 2420–2432, Sucheta Kulkarni, Leya Saju, Carol Farver and Raymond Tubbs

    Article first published online : 28 MAR 2012, DOI: 10.1002/ijc.27510

  3. Compatibility and stability of pertuzumab and trastuzumab admixtures in i.v. infusion bags for coadministration

    Journal of Pharmaceutical Sciences

    Volume 102, Issue 3, March 2013, Pages: 794–812, Zephania W. Kwong Glover, Lynn Gennaro, Sandeep Yadav, Barthélemy Demeule, Pin Yee Wong and Alavattam Sreedhara

    Article first published online : 5 DEC 2012, DOI: 10.1002/jps.23403

  4. Comparison of Subcutaneous and Intravenous Administration of Trastuzumab: A Phase I/Ib Trial in Healthy Male Volunteers and Patients With HER2-Positive Breast Cancer

    The Journal of Clinical Pharmacology

    Volume 53, Issue 2, February 2013, Pages: 192–201, Chris Wynne, Vernon Harvey, Christian Schwabe, Devonie Waaka, Christine McIntyre and Beate Bittner

    Article first published online : 22 FEB 2013, DOI: 10.1177/0091270012436560

  5. You have full text access to this OnlineOpen article
    Signal transduction of erbB receptors in trastuzumab (Herceptin) sensitive and resistant cell lines: Local stimulation using magnetic microspheres as assessed by quantitative digital microscopy

    Cytometry Part A

    Volume 67A, Issue 2, October 2005, Pages: 161–171, Elza Friedländer, Donna J. Arndt-Jovin, Péter Nagy, Thomas M. Jovin, János Szöllősi and György Vereb

    Article first published online : 14 SEP 2005, DOI: 10.1002/cyto.a.20173

  6. You have open access to this content
    Mechanisms of resistance to anti-human epidermal growth factor receptor 2 agents in breast cancer

    Cancer Science

    Volume 102, Issue 1, January 2011, Pages: 1–8, Toru Mukohara

    Article first published online : 6 SEP 2010, DOI: 10.1111/j.1349-7006.2010.01711.x

  7. You have full text access to this OnlineOpen article
    Adjuvant targeted therapy in early breast cancer

    Cancer

    Volume 115, Issue 6, 15 March 2009, Pages: 1154–1168, John Mackey, Deanna McLeod, Joseph Ragaz, Karen Gelmon, Sunil Verma, Kathleen Pritchard, Kara Laing, Louise Provencher and Lauren F. Charbonneau

    Article first published online : 22 JAN 2009, DOI: 10.1002/cncr.24114

  8. You have full text access to this OnlineOpen article
    Combined trastuzumab and paclitaxel treatment better inhibits ErbB-2-mediated angiogenesis in breast carcinoma through a more effective inhibition of Akt than either treatment alone

    Cancer

    Volume 98, Issue 7, 1 October 2003, Pages: 1377–1385, Kristine S. Klos, Xiaoyan Zhou, Sangkyou Lee, Lianglin Zhang, Wentao Yang, Yoichi Nagata and Dihua Yu

    Article first published online : 12 AUG 2003, DOI: 10.1002/cncr.11656

  9. You have full text access to this OnlineOpen article
    Use of adjuvant trastuzumab in women with human epidermal growth factor receptor 2 (HER2)-positive breast cancer by race/ethnicity and education within the National Comprehensive Cancer Network

    Cancer

    Volume 119, Issue 4, 15 February 2013, Pages: 839–846, Rachel A. Freedman, Melissa E. Hughes, Rebecca A. Ottesen, Jane C. Weeks, Yulei He, Yu-Ning Wong, Richard Theriault and Nancy L. Keating

    Article first published online : 25 SEP 2012, DOI: 10.1002/cncr.27831

  10. You have full text access to this OnlineOpen article
    Hormone receptor status influences the locoregional benefit of trastuzumab in patients with nonmetastatic breast cancer

    Cancer

    Volume 118, Issue 20, 15 October 2012, Pages: 4936–4943, Michelle M. Kim, Shaheenah Dawood, Pamela Allen, Aysegul A. Sahin, Wendy A. Woodward, Benjamin D. Smith, Eric A. Strom, Kelly K. Hunt, Funda Meric-Bernstam, Ana Maria Gonzalez-Angulo and Thomas A. Buchholz

    Article first published online : 17 APR 2012, DOI: 10.1002/cncr.27502

  11. Impact of Her-2-Targeted Therapy on Overall Survival in Patients With Her-2 Positive Metastatic Breast Cancer

    The Breast Journal

    Volume 19, Issue 2, March/April 2013, Pages: 149–155, Anna S. Berghoff, Zsuzsanna Bago-Horvath, Peter Dubsky, Margaretha Rudas, Ursula Pluschnig, Christoph Wiltschke, Michael Gnant, Guenther G. Steger, Christoph C. Zielinski and Rupert Bartsch

    Article first published online : 27 JAN 2013, DOI: 10.1111/tbj.12070

  12. Detection, monitoring, and management of trastuzumab-induced left ventricular dysfunction: an actual challenge

    European Journal of Heart Failure

    Volume 14, Issue 2, February 2012, Pages: 130–137, Carlo G. Tocchetti, Gianluca Ragone, Carmela Coppola, Domenica Rea, Giovanna Piscopo, Stefania Scala, Claudia De Lorenzo, Rosario V. Iaffaioli, Claudio Arra and Nicola Maurea

    Article first published online : 18 FEB 2014, DOI: 10.1093/eurjhf/hfr165

  13. Ablation of Breast Cancer Cells Using Trastuzumab-Functionalized Multi-Walled Carbon Nanotubes and Trastuzumab-Diphtheria Toxin Conjugate

    Chemical Biology & Drug Design

    Volume 83, Issue 3, March 2014, Pages: 259–265, Mojtaba Oraki Kohshour, Sako Mirzaie, Majid Zeinali, Mansour Amin, Mohammad Said Hakhamaneshi, Ali Jalaili, Nader Mosaveri and Mostafa Jamalan

    Article first published online : 26 DEC 2013, DOI: 10.1111/cbdd.12244

  14. You have full text access to this OnlineOpen article
    Adjuvant trastuzumab reduces locoregional recurrence in women who receive breast-conservation therapy for lymph node-negative, human epidermal growth factor receptor 2-positive breast cancer

    Cancer

    Volume 118, Issue 8, 15 April 2012, Pages: 1982–1988, Ana P. Kiess, Heather L. McArthur, Kathleen Mahoney, Sujata Patil, Patrick G. Morris, Alice Ho, Clifford A. Hudis and Beryl McCormick

    Article first published online : 1 SEP 2011, DOI: 10.1002/cncr.26484

  15. You have full text access to this OnlineOpen article
    Cost-effectiveness analysis of trastuzumab in the adjuvant setting for treatment of HER2-positive breast cancer

    Cancer

    Volume 110, Issue 3, 1 August 2007, Pages: 489–498, Louis P. Garrison Jr, Deborah Lubeck, Deepa Lalla, Virginia Paton, Amylou Dueck and Edith A. Perez

    Article first published online : 25 JUN 2007, DOI: 10.1002/cncr.22806

  16. You have open access to this content
    Semiquantitative assessment of the microdistribution of fluorescence-labeled monoclonal antibody in small peritoneal disseminations of ovarian cancer

    Cancer Science

    Volume 101, Issue 3, March 2010, Pages: 820–825, Nobuyuki Kosaka, Mikako Ogawa, David S. Paik, Chang H. Paik, Peter L. Choyke and Hisataka Kobayashi

    Article first published online : 31 OCT 2009, DOI: 10.1111/j.1349-7006.2009.01423.x

  17. You have free access to this content
    E-cadherin expression on human carcinoma cell affects trastuzumab-mediated antibody-dependent cellular cytotoxicity through killer cell lectin-like receptor G1 on natural killer cells

    International Journal of Cancer

    Volume 128, Issue 9, 1 May 2011, Pages: 2125–2137, Chisako Yamauchi, Satoshi Fujii, Taichi Kimura, Takeshi Kuwata, Noriaki Wada, Hirofumi Mukai, Naoki Matsumoto, Masashi Fukayama and Atsushi Ochiai

    Article first published online : 8 MAR 2011, DOI: 10.1002/ijc.25803

  18. You have full text access to this OnlineOpen article
    Multiparameter noninvasive assessment of treatment susceptibility, drug target inhibition and tumor response guides cancer treatment

    International Journal of Cancer

    Volume 121, Issue 11, 1 December 2007, Pages: 2492–2500, Michael S. Gee, Rabi Upadhyay, Henry Bergquist, Ralph Weissleder, Lee Josephson and Umar Mahmood

    Article first published online : 7 AUG 2007, DOI: 10.1002/ijc.22995

  19. Primary trastuzumab resistance: new tricks for an old drug

    Annals of the New York Academy of Sciences

    Volume 1210, Issue 1, October 2010, Pages: 53–65, Jason A. Wilken and Nita J. Maihle

    Article first published online : 25 OCT 2010, DOI: 10.1111/j.1749-6632.2010.05782.x

  20. You have full text access to this OnlineOpen article
    Targeting endothelin A receptor enhances anti-proliferative and anti-invasive effects of the HER2 antibody trastuzumab in HER2-overexpressing breast cancer cells

    International Journal of Cancer

    Volume 127, Issue 3, 1 August 2010, Pages: 696–706, Jeanett Fischgräbe, Martin Götte, Katharina Michels, Ludwig Kiesel and Pia Wülfing

    Article first published online : 3 DEC 2009, DOI: 10.1002/ijc.25076